Study of SCT650C for Active Axial Spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests an investigational medication called SCT650C for people with active axial spondyloarthritis. It aims to see if it can reduce pain and inflammation better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of axial spondyloarthritis (a type of arthritis affecting the spine) with symptoms lasting at least 3 months.
- You must have moderate to severe active disease, meaning your spinal pain is at least 4 on a 0-to-10 scale and your disease activity score is at least 4.
- You must have tried NSAIDs (like ibuprofen) without enough help or you can’t take them due to side effects or other reasons.
- You cannot have had more than 2 prior TNF inhibitor treatments, or any prior treatment with an IL-17 inhibitor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tofacitinib (a pill that reduces inflammation) can help people with early-stage axial spondyloarthritis, a type of arthritis that mainly affects the spine and pelvis. It's for those who have had symptoms for 2 years or less and have active disease with signs of inflammation in MRI or blood tests.
This trial tests whether taking nonsteroidal anti-inflammatory drugs (NSAIDs) helps people with axial spondyloarthritis stay in remission and avoid future flare-ups. It’s meant to see if NSAIDs can reduce the chance of symptoms returning and keep disease activity low over time.
This study tests whether a pain-relief medication called acemetacin works well and is safe for people with axial spondyloarthritis, a type of inflammatory spine condition. Researchers will track your symptoms and side effects over time in a real-world setting.
This study tests a new medicine called 608 for people with non-radiographic axial spondyloarthritis (a type of inflammatory back pain). The goal is to see if it can reduce pain and inflammation.
This trial tests whether transplanting healthy stool bacteria (fecal microbiota transplantation) can reduce symptoms in people with axial spondyloarthritis (including ankylosing spondylitis) who are not improving enough with standard medicines. If you qualify, you may receive study capsules containing processed bacteria and be closely monitored for safety and symptom changes.
This trial studies an advanced “sensor-based” way to assess how your spine and hips move in people with axial spondyloarthritis. It may help researchers better measure function and choose/monitor treatment, especially for those considered for biologic therapy.
Hear when a new Axial Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.